openPR Logo
Press release

Virtual Clinical Trials Surge as Pharma Embraces Remote Patient Monitoring | Major Companies - IQVIA, ICON plc, Laboratory Corporation of America Holdings, Science 37

06-13-2025 10:02 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Virtual Clinical Trials Market

Virtual Clinical Trials Market

The Global Virtual Clinical Trials Market reached US$ 8.95 billion in 2024 and is expected to reach US$ 14.42 billion by 2033, growing at a CAGR of 5.5% during the forecast period 2025-2033.

Virtual Clinical Trials Market is comprehensively covered in the DataM Intelligence report, which offers critical data, industry trends, and market intelligence. The study delves into the competitive environment, assessing leading players on their product portfolios, pricing, financial health, strategic growth initiatives, and geographic expansion.

Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/virtual-clinical-trials-market?ca

Virtual clinical trials (VCTs) are research studies conducted remotely using digital technologies to monitor and collect data from participants, reducing the need for in-person visits. These trials leverage tools like telemedicine, mobile apps, wearable devices, and electronic health records to enhance accessibility, patient engagement, and data collection. VCTs offer a more flexible, cost-effective, and patient-centric approach to clinical research while maintaining regulatory compliance and data integrity.

Major players in the Virtual Clinical Trials market

The prominent players in Virtual Clinical Trials market research report are: IQVIA, ICON plc, Laboratory Corporation of America Holdings, Science 37, Parexel International Corporation, Oracle Corporation, Medidata Solutions, Signant Health, Veristat, LLC, Sanofi

The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.

Virtual Clinical Trials Market Key Development

Improved data accuracy and real-time monitoring are key drivers of the virtual clinical trials market. Wearables and digital tools enable continuous tracking of vital signs and medication adherence, enhancing data reliability and early detection of adverse events. This boosts patient engagement and protocol compliance, accelerating market growth.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/virtual-clinical-trials-market?ca

Virtual Clinical Trials Market Segments

By Study Design: Interventional Trials, Observational Trials, Expanded Access Trials

By Indication: Oncology, Neurology, Autoimmune/Inflammation, Cardiovascular Disease, Metabolic/Endocrinology, Infectious Disease, Ophthalmology, Others

By Phase: Phase I, Phase II, Phase III, Phase IV

The Virtual Clinical Trials industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.

Regions Covered:

The global Virtual Clinical Trials Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Virtual Clinical Trials Surge as Pharma Embraces Remote Patient Monitoring | Major Companies - IQVIA, ICON plc, Laboratory Corporation of America Holdings, Science 37 here

News-ID: 4065533 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Electric Vehicle Market to Nearly Double to US$ 1,194.54 Billion by 2032, Driven by Accelerating EV Adoption and Charging Infrastructure Expansion | DataM Intelligence
Electric Vehicle Market to Nearly Double to US$ 1,194.54 Billion by 2032, Driven …
According to DataM Intelligence, the global electric vehicle market reached US$ 599.50 billion in 2024 and is expected to reach US$ 1,194.54 billion by 2032, growing at a CAGR of 9% during the forecast period 2025-2032. Growth is propelled by rising consumer demand for sustainable mobility, favorable government policies and incentives, continuous improvements in battery technology, and expanding EV charging infrastructure worldwide. Get a Free Sample PDF Of This
Artificial Intelligence Market to Expand Rapidly at 29.4% CAGR Through 2031, Driven by Cross Industry AI Adoption and Technological Innovation | DataM Intelligence
Artificial Intelligence Market to Expand Rapidly at 29.4% CAGR Through 2031, Dri …
According to DataM Intelligence, the global artificial intelligence market is estimated to grow at a significant CAGR of approximately 29.4% during the forecast period 2024-2031. Growth is propelled by broad enterprise adoption of AI across industries such as healthcare, retail, BFSI, automotive, IT & telecom, and industrial sectors, coupled with accelerating advancements in machine learning, natural language processing, and computer vision technologies. Get a Free Sample PDF Of This Report
Generative AI Market to Skyrocket to US$ 1,022.41 Billion by 2032, Fueled by Enterprise AI Adoption and Platform Innovation | DataM Intelligence
Generative AI Market to Skyrocket to US$ 1,022.41 Billion by 2032, Fueled by Ent …
According to DataM Intelligence, the generative AI market reached US$ 45.56 billion in 2024 and is expected to reach US$ 1,022.41 billion by 2032, growing at an exceptional CAGR of 47.53% during the forecast period 2025-2032. Growth is driven by accelerating enterprise adoption of generative AI across business functions, rising demand for AI chatbots and agents, advances in large language models (LLMs), and increasing integration of generative AI into internal
Circular Economy Market to Reach US$ 355.44 Billion by 2032, Fueled by Sustainability Initiatives and Resource Optimization Technologies | DataM Intelligence
Circular Economy Market to Reach US$ 355.44 Billion by 2032, Fueled by Sustainab …
According to DataM Intelligence, the circular economy market was valued at US$ 149.86 billion in 2024 and is projected to reach US$ 355.44 billion by 2032, expanding at a robust CAGR of 11.40% from 2025 to 2032. Market growth is driven by increasing global sustainability mandates, rising adoption of advanced recycling and resource recovery technologies, and growing integration of circular business models such as Product-as-a-Service (PaaS) across consumer goods, automotive,

All 5 Releases


More Releases for Trials

Clinical Trials Management System Market Trends: How Decentralized Clinical Tria …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical Device Firms, CROs)- Market Outlook And Industry Analysis 2031" The global Clinical Trials Management System market is estimated to reach
Brazil Clinical Trials Market ANVISA Brazil Guidelines Brazil Clinical Trials Re …
Brazil Cancer Drugs Clinical Trials Insight 2024 Report Offering: • Brazil Clinical Trials Market Opportunity 2024 and 2030 (In US$ Billion) • Clinical Trials Regulatory Framework In Brazil • Total Number of Cancer Drugs In Clinical Trials In Brazil • Total Number Of Cancer Drugs Approved In Brazil • 400 Pages Clinical Trials Insight On All Cancer Drugs In Clinical Trials By Company, Indication and Phase • 80 Pages Clinical Insight On All Cancer Drugs Approved in Market By Company and Indication • Insight
Clinical Trials Management System Market Clinical Trials Management System Marke …
InsightAce Analytic announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical Device Firms, CROs)- Market Outlook And Industry Analysis 2031. The global Clinical Trials Management System market is estimated to reach over USD
Revolutionizing Clinical Trials: The Evolution of eCOA, eSource, and the Clinica …
The global eCOA, eSource & clinical trials market is valued at US$ 48 billion in 2023 and is expected to reach a market size of US$ 104 billion by the end of 2033, expanding rapidly at a CAGR of 8% over the next ten years. Worldwide demand for eCOA (electronic clinical outcome assessment) solutions is predicted to rise at a CAGR of 8.2% over the forecast period. In the dynamic landscape
Virtual Clinical Trials Market - Bridging the Gap: Virtual Clinical Trials Revol …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Virtual Clinical Trials Market. Virtual Clinical Trials Market: https://www.growthplusreports.com/report/virtual-clinical-trials-market/9106 The Virtual Clinical Trials Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the
Clinical Trials Market: Coronavirus Pandemic Pushes Sponsors, Patients to Adopt …
Clinical trials Market: Introduction According to the report, the global clinical trials market was valued over US$ 46.7 Bn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030. High prevalence and increase in incidence rate of chronic diseases, and rise in R&D activities in biotechnology & pharmaceuticals industries are anticipated to drive the global clinical trials market from 2020 to 2030. North America is projected to